Amundi Amneal Pharmaceuticals, Inc. Transaction History
Amundi
- $275 Billion
- Q4 2024
A detailed history of Amundi transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Amundi holds 31,764 shares of AMRX stock, worth $248,394. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,764Holding current value
$248,394% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
199Shares Held
142MCall Options Held
57KPut Options Held
59K-
Ubs Group Ag21.8MShares$170 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.8MShares$116 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$96.4 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$88.2 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$83.8 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.18B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...